Abiopharma

(30% Negative) VIRTRA, INC (VTSI) Reports Q1 2026 Financial Results

(100% Positive) WRAP TECHNOLOGIES, INC. (WRAP) Reports Q1 2026 Financial Results

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

(99% Neutral) TETRA TECH INC (TTEK) Files Form 8-K

📋 HAROLD SELICK (Director) plans to sell 24K shares of PROTAGONIST THERAPEUTICS, INC. (at $105.00 each, total $2.5M) Filed: Mar 26, 2026 | ID: 003020

FORESIGHT AUTONOMOUS HOLDINGS LTD (FRSX) Files Form 6-K

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Nuvation Bio Inc. - Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency

📋 JESSICA GARASCIA (Officer) plans to sell 6K shares of AAR CORP. (at $112.20 each, total $705K) Filed: Mar 26, 2026 | ID: 003019

Director NOLAN PETER J 🔴 sold 6.3K shares of Limoneira CO (LMNR) Transaction Date: Mar 25, 2026 | Filing ID: 035173

📋 ASIF ALI (Officer) plans to sell 25K shares of PROTAGONIST THERAPEUTICS, INC. (at $104.24 each, total $2.6M) Filed: Mar 26, 2026 | ID: 003018

(99% Neutral) PAYCOM SOFTWARE, INC. (PAYC) Announces Executive Departure

(99% Neutral) LAUNCH ONE ACQUISITION CORP. (LPAAU) Announces Business Combination

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

(30% Negative) APTEVO THERAPEUTICS INC. (APVO) Reports Q1 2026 Financial Results